Assessment of physiologic natural killer cell cytotoxicity in vitro

Human Immunology

Volumn 72, Issue 11, 2011, Pages 1007-1012

  Duske, Heidi ^a   Sputtek, Andreas ^a   Binder, Thomas ^a   Kröger, Nicolaus ^a   Schrepfer, Sonja ^a   Eiermann, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

51Cr release; K562; Leukemia; Natural killer cells

Indexed keywords

CRYOPROTECTIVE AGENT; DIMETHYL SULFOXIDE; INTERLEUKIN 2;

ARTICLE; CELL ACTIVITY; CELL SEPARATION; CELL STIMULATION; CHROMIUM 51 RELEASE; CRYOPRESERVATION; CYTOLYSIS; CYTOTOXICITY; FREEZING; HUMAN; HUMAN CELL; IN VITRO STUDY; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; THAWING; VALIDATION STUDY;

CALIBRATION; CELLS, CULTURED; CHLORIDES; CHROMIUM COMPOUNDS; CRYOPRESERVATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; FEASIBILITY STUDIES; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; TISSUE AND ORGAN HARVESTING; TRANSPLANTATION IMMUNOLOGY;

EID: 80054118035     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.08.006     Document Type: Article

References (39)

1. Parham P. Innate immunity: The unsung heroes. Nature 2003, 423:20.
2. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat Immunol 2008, 9:503-510.
3. Raulet D.H., Held W. Natural killer cell receptors: The offs and ons of NK cell recognition. Cell 1995, 82:697-700.
4. Middleton D., Gonzelez F. The extensive polymorphism of KIR genes. Immunology 2010, 129:8-19.
5. Ljunggren H.G., Kärre K. In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today 1990, 11:237-244.
6. Anfossi N., André P., Guia S., Falk C.S., Roetynck S., Stewart C.A., et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006, 25:331-342.
7. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.-J., Yang L., et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005, 436:709-713.
8. Fernandez N.C., Treiner E., Vance R.E., Jamieson A.M., Lemieux S., Raulet D.H. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005, 105:4416-4423.
9. Wagtmann N., Biassoni R., Cantoni C., Verdiani S., Malnati M.S., Vitale M., et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995, 2:439-449.
10. Falk C.S., Steinle A., Schendel D.J. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells. J Exp Med 1995, 182:1005-1018.
11. Moretta L., Moretta A. Killer immunoglobulin-like receptors. Curr Opin Immunol 2004, 16:626-633.
12. Stern M., Ruggeri L., Capanni M., Mancusi A., Velardi A. Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. Blood 2008, 112:708-710.
13. Fauriat C., Ivarsson M.A., Ljunggren H.-G., Malmberg K.-J., Michaëlsson J. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 2010, 115:1166-1174.
14. Cognet C., Farnarier C., Gauthier L., Frassati C., André P., Magérus-Chatinet A., et al. Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells. Clin Immunol 2010, 135:26-32.
15. Uhrberg M., Parham P., Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002, 54:221-229.
16. Niederwieser D., Gastl G., Rumpold H., Marth C., Kraft D., Huber C. Rapid reappearance of large granular lymphocytes (LGL) with concomitant reconstitution of natural killer (NK) activity after human bone marrow transplantation (BMT). Br J Haematol 1987, 65:301-305.
17. Bignon J.-D., Gagne K. KIR matching in hematopoietic stem cell transplantation. Curr Opin Immunol 2005, 17:553-559.
18. Pende D., Marcenaro S., Falco M., Martini S., Bernardo M.E., Montagna D., et al. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: Evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 2009, 113:3119-3129.
19. Feuchtinger T., Pfeiffer M., Pfaffle A., Teltschik H.-M., Wernet D., Schumm M., et al. Cytolytic activity of NK cell clones against acute childhood precursor-B-cell leukaemia is influenced by HLA class I expression on blasts and the differential KIR phenotype of NK clones. Bone Marrow Transplant 2009, 43:875-881.
20. Kröger N., Binder T., Zabelina T., Wolschke C., Schieder H., Renges H., et al. Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation. Transplantation 2006, 82:1024-1030.
21. McQueen K.L., Dorighi K.M., Guethlein L.A., Wong R., Sanjanwala B., Parham P. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation. Hum Immunol 2007, 68:309-323.
22. Cooley S., Weisdorf D.J., Guethlein L.A., Klein J.P., Wang T., Le C.T., et al. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood 2010, 116:2411-2419.
23. Witt C.S. The influence of NK alloreactivity on matched unrelated donor and HLA identical sibling haematopoietic stem cell transplantation. Curr Opin Immunol 2009, 21:531-537.
24. Cooley S., McCullar V., Wangen R., Bergemann T.L., Spellman S., Weisdorf D.J., et al. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood 2005, 106:4370-4376.
25. David G., Morvan M., Gagne K., Kerdudou N., Willem C., Devys A., et al. Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies. Immunology 2009, 128:172-184.
26. Della Chiesa M., Romeo E., Falco M., Balsamo M., Augugliaro R., Moretta L., et al. Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. Eur J Immunol 2008, 38:2284-2289.
27. Gabriel I.H., Sergeant R., Szydlo R., Apperley J.F., DeLavallade H., Alsuliman A., et al. Interaction between KIR3DS1 and HLA-Bw4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myeloma. Blood 2010, 116:2033-2039.
28. Verheyden S., Ferrone S., Mulder A., Claas F.H., Schots R., De Moerloose B., et al. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by natural killer cells. Cancer Immunol Immunother 2009, 58:855-865.
29. Disis M.L., dela Rosa C., Goodell V., Kuan L.-Y., Chang J.C.C., Kuus-Reichel K., et al. Maximizing the retention of antigen specific lymphocyte function after cryopreservation. J Immunol Methods 2006, 308:13-18.
30. Betensky R.A., Connick E., Devers J., Landay A.L., Nokta M., Plaeger S., et al. Shipment impairs lymphocyte proliferative responses to microbial antigens. Clin Diagn Lab Immunol 2000, 7:759-763.
31. Sputtek A., Körber C. Cryopreservation of red blood cells, platelets, lymphocytes, and stem cells. Clinical Applications of Cryobiology 1991, 95-147. CRC Press, Boca Raton, FL. B.J. Fuller, B.W.W. Grout (Eds.).
32. Pegg D.E. Principles of Cryopreservation. Cryopreservation and Freeze-Drying Protocols 2007, 39-57. Humana Press, Totowa, NJ. J.G. Day, G.N. Stacey (Eds.).
33. Rowley S.D., Anderson G.L. Effect of DMSO exposure without cryopreservation on hematopoietic progenitor cells. Bone Marrow Transplant 1993, 11:389-393.
34. Fahy G. Cryoprotectant toxicity neutralization. Cryobiology 2010, 60:45-53.
35. Martí F., Miralles A., Peiró M., Amill B., de Dalmases C., Piñol G., et al. Differential effect of cryopreservation on natural killer cell and lymphokine-activated killer cell activities. Transfusion 1993, 33:651-655.
36. Berg M., Lundqvist A., McCoy P., Samsel L., Fan Y., Tawab A., et al. Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells. Cytotherapy 2009, 11:341-355.
37. de Rham C., Ferrari-Lacraz S., Jendly S., Schneiter G., Dayer J.-M., Villard J. The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors. Arthritis Res Ther 2007, 9:R125.
38. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001, 19:197-223.
39. Chrul S., Polakowska E., Szadkowska A., Bodalski J. Influence of interleukin IL-2 and IL-12 + IL-18 on surface expression of immunoglobulin-like receptors KIR2DL1, KIR2DL2, and KIR3DL2 in natural killer cells. Mediators Inflamm 2006, 2006:46957.